0 results for 'Price Law'
Judges Hear 1st Challenge to Medicare Drug Price Program to Hit Federal Appeals Court
The challenge to the program seems to be a part of a larger legal strategy to create a circuit split, thus increasing chances of U.S. Supreme Court review, said Andrew Twinamatsiko, director of the Health Policy and the Law Initiative at the O'Neill Institute.
Law.com Pro Webcast: Breaking Down the Impact of AI on Big Law Economics
Register for the webcast, streaming live Thursday at 11 ET, where the panel will break down how Gen AI will affect demand, pricing, staffing, profitability, competition and more.
Chancery Court Emphasizes Nexus Between Unclean Hands Defense and Asserted Claims
In Pilot v. Greg Abel, Vice Chancellor Morgan T. Zurn granted a motion to strike the defenses of unclean hands and in pari delicto because the defenses lacked a sufficient nexus to the contractual claims asserted by the plaintiff.
White-Collar Boutique Launches in DC With Former SEC Official, Cranfill Sumner Partners
Former SEC official Christina Zaroulis Milnor will help launch a new boutique in D.C.
Law Journal Press | Digital Book
Connecticut Appellate Practice & Procedure, 8th Edition
Authors: HON. ELIOT D. PRESCOTT, JULIE A. LAVOIE
View this Book
View more book results for the query "Price Law"
Why the Future of Talent Management Could Look Very Different
With the introduction and accelerating adoption of efficiency-generating technologies, the way lawyers are recruited and developed is likely to undergo some interesting changes.
Boehringer Ingelheim Accused of Using Expired Patents to Control Market
Jason Ginenthal, a spokesperson for Boehringer Ingelheim, said the company "has never wrongfully submitted patents for listing in the Orange Book."
Increased IRS Enforcement Helped Chamberlain Hrdlicka Grow Revenues, Profits in 2023
The Southeast being "kind of the epicenter of IRS enforcement" involving conservation easement disputes in 2023 was the main driver of increased profits, the managing shareholder said.
Ex-HP CEO Apotheker Defends Rationale for $11B Autonomy Purchase That Blew Up
Leo Apotheker said he relied on Autonomy's financials when he championed the deal. Prosecutors accuse its CEO, Michael Lynch, of fabricating those numbers.
Nominal Sale Bid – The Court Stumbles (Partly)
In a continuation of his discussion on the efficacy of a plaintiff's nominal bid at a foreclosure sale, Bruce Bergman takes issue with the Third Department in its ruling in 'Wilmington Savings Fund Society FSB v. Oppitz.'TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Vaishali Rao, Hinshaw & Culbertson Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now